0001127602-24-009546.txt : 20240311 0001127602-24-009546.hdr.sgml : 20240311 20240311211409 ACCESSION NUMBER: 0001127602-24-009546 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240310 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Parsey Merdad CENTRAL INDEX KEY: 0001792150 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 24740028 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-10 0000882095 GILEAD SCIENCES, INC. GILD 0001792150 Parsey Merdad GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 Chief Medical Officer 0 Common Stock 2024-03-10 4 M 0 3455 A 96161 D Common Stock 2024-03-10 4 M 0 6946 A 103107 D Common Stock 2024-03-10 4 F 0 4803 75.12 D 98304 D Restricted Stock Unit 2024-03-10 4 M 0 3455 D Common Stock 3455 37520 D Restricted Stock Unit 2024-03-10 4 M 0 6946 D Common Stock 6946 30574 D Non-qualified Stock Option (Right to Buy) 75.12 2024-03-10 4 A 0 89660 0 A 2034-03-10 Common Stock 89660 89660 D Restricted Stock Unit 2024-03-10 4 A 0 17640 A Common Stock 17640 48214 D Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. /s/ Amy Kim by Power of Attorney for Merdad Parsey 2024-03-11